アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/01/31 | 1,529 | 1,529.5 | 1,513 | 1,514.5 | -14.5 | -0.9% | 5,353,700 |
2025/01/30 | 1,531.5 | 1,535 | 1,519 | 1,529 | -2.5 | -0.2% | 3,348,500 |
2025/01/29 | 1,535 | 1,537 | 1,519.5 | 1,531.5 | -7 | -0.5% | 5,297,700 |
2025/01/28 | 1,532.5 | 1,553 | 1,527 | 1,538.5 | +20 | +1.3% | 5,634,600 |
2025/01/27 | 1,508.5 | 1,527.5 | 1,507 | 1,518.5 | +16.5 | +1.1% | 6,081,200 |
2025/01/24 | 1,500 | 1,514.5 | 1,492.5 | 1,502 | +24 | +1.6% | 4,080,600 |
2025/01/23 | 1,477 | 1,482 | 1,460.5 | 1,478 | -8 | -0.5% | 4,945,100 |
2025/01/22 | 1,492.5 | 1,497.5 | 1,484 | 1,486 | -2 | -0.1% | 4,282,300 |
2025/01/21 | 1,489.5 | 1,498 | 1,484 | 1,488 | +2.5 | +0.2% | 2,979,000 |
2025/01/20 | 1,494 | 1,496.5 | 1,476 | 1,485.5 | -8.5 | -0.6% | 5,536,000 |
2025/01/17 | 1,504 | 1,507 | 1,490 | 1,494 | -10.5 | -0.7% | 5,580,800 |
2025/01/16 | 1,525 | 1,526 | 1,504.5 | 1,504.5 | -24 | -1.6% | 4,719,800 |
2025/01/15 | 1,539 | 1,559.5 | 1,528.5 | 1,528.5 | +12 | +0.8% | 7,174,400 |
2025/01/14 | 1,513.5 | 1,523 | 1,502 | 1,516.5 | +6.5 | +0.4% | 8,152,200 |
2025/01/10 | 1,530 | 1,535.5 | 1,507 | 1,510 | -26 | -1.7% | 8,082,200 |
2025/01/09 | 1,522 | 1,544.5 | 1,513.5 | 1,536 | +15 | +1% | 6,352,500 |
2025/01/08 | 1,532 | 1,540.5 | 1,521 | 1,521 | -16 | -1% | 4,685,800 |
2025/01/07 | 1,534.5 | 1,544 | 1,528 | 1,537 | +10 | +0.7% | 4,581,500 |
2025/01/06 | 1,535 | 1,536.5 | 1,516.5 | 1,527 | -7.5 | -0.5% | 7,168,100 |
2024/12/30 | 1,548.5 | 1,551 | 1,533 | 1,534.5 | -10 | -0.6% | 5,159,600 |
2024/12/27 | 1,530 | 1,550 | 1,530 | 1,544.5 | +15 | +1% | 5,433,500 |
2024/12/26 | 1,517 | 1,529.5 | 1,517 | 1,529.5 | +8.5 | +0.6% | 4,790,900 |
2024/12/25 | 1,539.5 | 1,541 | 1,513.5 | 1,521 | -9.5 | -0.6% | 4,191,500 |
2024/12/24 | 1,524.5 | 1,535 | 1,516 | 1,530.5 | +11.5 | +0.8% | 3,981,100 |
2024/12/23 | 1,530 | 1,534 | 1,507.5 | 1,519 | -23.5 | -1.5% | 5,027,300 |
2024/12/20 | 1,528 | 1,544.5 | 1,525.5 | 1,542.5 | +22.5 | +1.5% | 9,307,400 |
2024/12/19 | 1,507 | 1,526 | 1,501.5 | 1,520 | +10.5 | +0.7% | 4,881,400 |
2024/12/18 | 1,510 | 1,517 | 1,504.5 | 1,509.5 | -7 | -0.5% | 5,961,800 |
2024/12/17 | 1,517 | 1,523.5 | 1,507 | 1,516.5 | -10.5 | -0.7% | 7,153,400 |
2024/12/16 | 1,552.5 | 1,556 | 1,522 | 1,527 | -29.5 | -1.9% | 5,263,800 |
2024/12/13 | 1,553 | 1,570 | 1,547 | 1,556.5 | -25 | -1.6% | 7,713,400 |
2024/12/12 | 1,576 | 1,589 | 1,573.5 | 1,581.5 | +7 | +0.4% | 4,357,900 |
2024/12/11 | 1,577.5 | 1,592.5 | 1,570.5 | 1,574.5 | -6 | -0.4% | 4,426,400 |
2024/12/10 | 1,598.5 | 1,599.5 | 1,575 | 1,580.5 | -2 | -0.1% | 3,738,500 |
2024/12/09 | 1,581 | 1,592.5 | 1,575.5 | 1,582.5 | +1.5 | +0.1% | 3,362,900 |
2024/12/06 | 1,591 | 1,596 | 1,576 | 1,581 | -12 | -0.8% | 3,658,200 |
2024/12/05 | 1,604 | 1,608 | 1,587.5 | 1,593 | -12.5 | -0.8% | 3,855,800 |
2024/12/04 | 1,606.5 | 1,609 | 1,595 | 1,605.5 | -14.5 | -0.9% | 4,088,400 |
2024/12/03 | 1,600 | 1,624.5 | 1,595 | 1,620 | +36 | +2.3% | 6,375,200 |
2024/12/02 | 1,570 | 1,589 | 1,564 | 1,584 | +22.5 | +1.4% | 4,225,100 |
2024/11/29 | 1,560 | 1,570 | 1,549 | 1,561.5 | -10 | -0.6% | 5,503,400 |
2024/11/28 | 1,562.5 | 1,574 | 1,555 | 1,571.5 | +4.5 | +0.3% | 3,743,400 |
2024/11/27 | 1,572 | 1,578.5 | 1,561.5 | 1,567 | -5 | -0.3% | 3,421,600 |
2024/11/26 | 1,568 | 1,572 | 1,552.5 | 1,572 | ±0 | ±0% | 4,036,300 |
2024/11/25 | 1,598 | 1,601.5 | 1,570 | 1,572 | +10 | +0.6% | 14,539,600 |
2024/11/22 | 1,575 | 1,577.5 | 1,559 | 1,562 | -10 | -0.6% | 5,561,900 |
2024/11/21 | 1,585 | 1,598.5 | 1,570 | 1,572 | -0.5 | ±0% | 5,667,600 |
2024/11/20 | 1,573.5 | 1,580.5 | 1,561.5 | 1,572.5 | +11.5 | +0.7% | 4,935,500 |
2024/11/19 | 1,578 | 1,585 | 1,544 | 1,561 | -53.5 | -3.3% | 10,715,900 |
2024/11/18 | 1,656 | 1,660 | 1,612 | 1,614.5 | -56 | -3.4% | 6,837,200 |
1~
50
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム